These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2442554)

  • 1. Renal effects of converting enzyme inhibition.
    Brunner HR; Waeber B; Nussberger J
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S6-14. PubMed ID: 2442554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
    Humke U; Levens N; Wood J; Hofbauer K
    J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal response to angiotensin after short-term angiotensin converting enzyme inhibition.
    Hannedouche T; Schmitt F; Ikeni A; Marques LP; Natov S; Déchaux M; Lacour B; Grünfeld JP
    Hypertension; 1993 Mar; 21(3):261-6. PubMed ID: 7682991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal perfusion and function. The implications of converting enzyme inhibition.
    Hollenberg NK
    Am J Med; 1988 Apr; 84(4A):9-15. PubMed ID: 3064608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal response to angiotensin-converting enzyme inhibition.
    Hollenberg NK
    Am J Cardiol; 1982 Apr; 49(6):1425-9. PubMed ID: 6176107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure related to angiotensin-converting enzyme inhibitors.
    Textor SC
    Semin Nephrol; 1997 Jan; 17(1):67-76. PubMed ID: 9000551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in rats.
    Koelz AM; Bertschin S; Hermle M; Mihatsch M; Brunner FP; Thiel G
    Experientia; 1988 Feb; 44(2):172-5. PubMed ID: 2831078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal morphology and function in dogs after treatment with the angiotensin-converting enzyme inhibitor quinapril.
    Susick RL; Dominick MA; Ulloa HM; Pegg DG
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):275-82. PubMed ID: 7511758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition and the normal kidney.
    Brunner HR; Waeber B; Nussberger J
    Kidney Int Suppl; 1987 May; 20():S104-7. PubMed ID: 3037158
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP; Natov S; Boitard C; Lacour B; Grünfeld JP
    Nephrol Dial Transplant; 1996 Apr; 11(4):673-8. PubMed ID: 8671857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system, converting-enzyme inhibition and kidney function in aging female rats.
    Corman B; Michel JB
    Am J Physiol; 1986 Sep; 251(3 Pt 2):R450-5. PubMed ID: 3019163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of angiotensin II in normotensive subjects on short-term cilazapril treatment.
    Hannedouche T; Ikeni A; Marques LP; Natov S; Dechaux M; Schmitt F; Lacour B; Grünfeld JP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S25-7. PubMed ID: 1382161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.